Xiao‐Jiao Li

634 total citations
25 papers, 474 citations indexed

About

Xiao‐Jiao Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xiao‐Jiao Li has authored 25 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xiao‐Jiao Li's work include Ferroptosis and cancer prognosis (6 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Xiao‐Jiao Li is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Xiao‐Jiao Li collaborates with scholars based in China and New Zealand. Xiao‐Jiao Li's co-authors include Gang Chen, Peng Lin, Rong‐Quan He, Hong Yang, Yun He, Qing Li, Yi‐Wu Dang, Jie Ma, Xiaohua Hu and Lin Shi and has published in prestigious journals such as Journal of Ethnopharmacology, Estuarine Coastal and Shelf Science and BMC Cancer.

In The Last Decade

Xiao‐Jiao Li

24 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao‐Jiao Li China 14 297 168 122 84 47 25 474
Margit Pacher Austria 7 517 1.7× 131 0.8× 54 0.4× 172 2.0× 53 1.1× 7 694
Hirofumi Matsuda Japan 11 191 0.6× 122 0.7× 71 0.6× 83 1.0× 35 0.7× 26 488
Hilde Elise Førde Norway 5 266 0.9× 134 0.8× 105 0.9× 93 1.1× 8 0.2× 7 470
Myles C. Hodgson United States 11 357 1.2× 116 0.7× 214 1.8× 88 1.0× 73 1.6× 14 565
Ximena Leighton United States 13 441 1.5× 117 0.7× 124 1.0× 61 0.7× 43 0.9× 21 597
Elena Panizza United States 11 290 1.0× 114 0.7× 57 0.5× 73 0.9× 29 0.6× 19 399
Wenzheng Fang China 13 330 1.1× 149 0.9× 81 0.7× 124 1.5× 20 0.4× 28 453
James M. Arnold United States 10 269 0.9× 219 1.3× 104 0.9× 78 0.9× 33 0.7× 11 408
R Mukherjee United Kingdom 8 293 1.0× 158 0.9× 230 1.9× 213 2.5× 44 0.9× 14 604
Angelika Tölle Germany 14 365 1.2× 241 1.4× 217 1.8× 138 1.6× 10 0.2× 21 696

Countries citing papers authored by Xiao‐Jiao Li

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Jiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Jiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Jiao Li more than expected).

Fields of papers citing papers by Xiao‐Jiao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Jiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Jiao Li. The network helps show where Xiao‐Jiao Li may publish in the future.

Co-authorship network of co-authors of Xiao‐Jiao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Jiao Li. A scholar is included among the top collaborators of Xiao‐Jiao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Jiao Li. Xiao‐Jiao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Chang Myeon, Yu‐Yan Pang, Rong‐Quan He, et al.. (2024). Historical context, process, and development trends of pediatric thyroid cancer research: a bibliometric analysis. Frontiers in Oncology. 14. 1340872–1340872.
2.
3.
Huang, Su-Ning, Gang Chen, Yu‐Yan Pang, et al.. (2020). Clinicopathological value and underlying molecular mechanism of annexin A2 in 992 cases of thyroid carcinoma. Computational Biology and Chemistry. 86. 107258–107258. 8 indexed citations
4.
Lin, Peng, Yuting Peng, Wei Yan, et al.. (2020). Radiomic profiles in diffuse glioma reveal distinct subtypes with prognostic value. Journal of Cancer Research and Clinical Oncology. 146(5). 1253–1262. 18 indexed citations
5.
Guo, Wanping, Yu‐Yan Pang, Xiao‐Jiao Li, et al.. (2020). Immunohistochemical basigin expression level in thyroid cancer tissues. World Journal of Surgical Oncology. 18(1). 240–240. 4 indexed citations
6.
Chen, Shangwei, Huiping Lu, Gang Chen, et al.. (2020). Downregulation of miRNA‐126‐3p is associated with progression of and poor prognosis for lung squamous cell carcinoma. FEBS Open Bio. 10(8). 1624–1641. 11 indexed citations
7.
Li, Xiao‐Jiao, Rong Wen, Dong‐yue Wen, et al.. (2020). Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancer. Molecular Medicine Reports. 22(3). 2199–2218. 10 indexed citations
8.
Lin, Peng, Yu‐Yan Pang, Huayu Wu, et al.. (2019). Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma.. PubMed Central. 11(11). 6754–6774. 17 indexed citations
9.
Rong, Minhua, Yi‐Wu Dang, Rong‐Quan He, et al.. (2019). Differentially expressed gene profile and relevant pathways of the traditional Chinese medicine cinobufotalin on MCF‑7 breast cancer cells. Molecular Medicine Reports. 19(5). 4256–4270. 14 indexed citations
10.
Lin, Peng, Rong‐Quan He, Zhi‐Guang Huang, et al.. (2019). Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis. Aging. 11(7). 2082–2097. 29 indexed citations
11.
Dang, Yi‐Wu, Peng Lin, Limin Liu, et al.. (2018). In silico analysis of the potential mechanism of telocinobufagin on breast cancer MCF-7 cells. Pathology - Research and Practice. 214(5). 631–643. 10 indexed citations
12.
13.
Li, Xiao‐Jiao, et al.. (2018). Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining. Pathology - Research and Practice. 214(3). 385–401. 13 indexed citations
14.
Liang, Shengkang, et al.. (2018). Composition and bioavailability of dissolved organic matter in different water masses of the East China sea. Estuarine Coastal and Shelf Science. 212. 189–202. 26 indexed citations
15.
Lin, Peng, Xiao‐Jiao Li, Rong‐Quan He, et al.. (2018). Development of a Prognostic Index Based on an Immunogenomic Landscape Analysis of Papillary Thyroid Cancer. SSRN Electronic Journal. 8 indexed citations
16.
He, Rong‐Quan, Xiao‐Jiao Li, Lu Liang, et al.. (2017). The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model. BMC Cancer. 17(1). 655–655. 46 indexed citations
17.
Li, Xiao‐Jiao, Yantong Sun, Lei Yin, et al.. (2012). Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC–MS/MS: Method development, validation and application to pharmacokinetics. Journal of Pharmaceutical Analysis. 3(1). 1–8. 6 indexed citations
18.
Li, Xiao‐Jiao, Song-Feng Zhao, & Xiaoxin Zhou. (2012). Investigation of Angular Dependence of Strong-Field Tunneling Ionization for Asymmetric Diatomic Molecule HeH 2+. Communications in Theoretical Physics. 58(3). 419–424. 4 indexed citations
19.
Liu, Wanhui, Chunjie Sha, Yinglin Wang, et al.. (2012). Pharmacokinetics and bioavailability of cimicifugosides after oral administration of Cimicifuga foetida L. extract to rats. Journal of Ethnopharmacology. 143(1). 249–255. 15 indexed citations
20.
Zhang, Mengliang, Feng Gao, Qun He, et al.. (2011). Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat. Journal of Ethnopharmacology. 139(1). 201–206. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margit Pacher Breakdown of academic impact, for papers by Hirofumi Matsuda Breakdown of academic impact, for papers by Hilde Elise Førde Breakdown of academic impact, for papers by Myles C. Hodgson Breakdown of academic impact, for papers by Ximena Leighton Breakdown of academic impact, for papers by Elena Panizza Breakdown of academic impact, for papers by Wenzheng Fang Breakdown of academic impact, for papers by James M. Arnold Breakdown of academic impact, for papers by R Mukherjee Breakdown of academic impact, for papers by Angelika Tölle
Rankless by CCL
2026